{"name": "Okairos",
 "permalink": "okairos",
 "crunchbase_url": "http://www.crunchbase.com/company/okairos",
 "homepage_url": "http://www.okairos.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@okairos.com",
 "phone_number": "+39 06 97246470",
 "description": "bio-pharmaceutical company",
 "created_at": "Wed Sep 15 18:45:47 UTC 2010",
 "updated_at": "Wed Sep 15 18:53:50 UTC 2010",
 "overview": "\u003Cp\u003EOkairos AG, a bio-pharmaceutical company, focuses on the discovery and development of genetic T-cell vaccines, including hepatitis C virus. The company also provides health and allied services. It has operations in Rome and Naples, Italy. \u003C/p\u003E\n\n\u003Cp\u003EThe company is based in Basel, Switzerland. Okairos AG was former subsidiary of Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       94],
      "assets/images/resized/0010/1873/101873v1-max-150x150.jpg"],
     [[222,
       140],
      "assets/images/resized/0010/1873/101873v1-max-250x250.jpg"],
     [[222,
       140],
      "assets/images/resized/0010/1873/101873v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Bradley",
      "last_name": "Bolzon",
      "permalink": "bradley-bolzon",
      "image":
       {"available_sizes":
         [[[112,
            112],
           "assets/images/resized/0025/7863/257863v1-max-150x150.jpg"],
          [[112,
            112],
           "assets/images/resized/0025/7863/257863v1-max-250x250.jpg"],
          [[112,
            112],
           "assets/images/resized/0025/7863/257863v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$20.5M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.fiercebiotech.com/story/italys-okairos-raises-20-5m-vaccine-work/2010-09-14?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Italy's Okairos raises $20.5M for vaccine work",
    "raised_amount": 20500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 9,
    "funded_day": 14,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Versant Ventures",
         "permalink": "versant-ventures",
         "image":
          {"available_sizes":
            [[[150,
               30],
              "assets/images/resized/0004/6455/46455v2-max-150x150.jpg"],
             [[190,
               38],
              "assets/images/resized/0004/6455/46455v2-max-250x250.jpg"],
             [[190,
               38],
              "assets/images/resized/0004/6455/46455v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Boehringer Ingelheim Venture Fund",
         "permalink": "boehringer-ingelheim-venture-fund",
         "image":
          {"available_sizes":
            [[[135,
               40],
              "assets/images/resized/0023/2429/232429v2-max-150x150.png"],
             [[135,
               40],
              "assets/images/resized/0023/2429/232429v2-max-250x250.png"],
             [[135,
               40],
              "assets/images/resized/0023/2429/232429v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 325000000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.fool.com/investing/general/2013/05/29/glaxosmithkline-acquires-okairos-for-325-million.aspx",
   "source_description": "GlaxoSmithKline Acquires Okairos for $325 Million ",
   "acquired_year": 2013,
   "acquired_month": 5,
   "acquired_day": 29,
   "acquiring_company":
    {"name": "GlaxoSmithKline",
     "permalink": "glaxosmithkline",
     "image":
      {"available_sizes":
        [[[150,
           51],
          "assets/images/resized/0005/1020/51020v1-max-150x150.png"],
         [[158,
           54],
          "assets/images/resized/0005/1020/51020v1-max-250x250.png"],
         [[158,
           54],
          "assets/images/resized/0005/1020/51020v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "Elisabethenstrasse 3",
    "address2": "",
    "zip_code": "CH 4051",
    "city": "Basel",
    "state_code": null,
    "country_code": "CHE",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        104],
       "assets/images/resized/0010/1876/101876v1-max-150x150.jpg"],
      [[250,
        174],
       "assets/images/resized/0010/1876/101876v1-max-250x250.jpg"],
      [[450,
        313],
       "assets/images/resized/0010/1876/101876v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}